Provided by Tiger Fintech (Singapore) Pte. Ltd.

Myers

15.53
-0.1000-0.64%
Post-market: 15.530.00000.00%16:23 EDT
Volume:92.70K
Turnover:1.44M
Market Cap:580.55M
PE:55.43
High:15.77
Open:15.61
Low:15.35
Close:15.63
Loading ...

David Myers, a Conservationist With the Mindset of a Developer, Dies at 73 -- Journal Report

Dow Jones
·
21 Mar

Bristol Myers Squibb Co. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
15 Mar

Investors Can Find Comfort In Myers Industries' (NYSE:MYE) Earnings Quality

Simply Wall St.
·
14 Mar

Bristol Myers Gets Expanded European Approval for Breyanzi

Dow Jones
·
14 Mar

Bristol Myers announces EC approval of Breyanzi

TIPRANKS
·
14 Mar

Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma

Business Wire
·
14 Mar

Press Release: Bristol Myers Squibb to Report Results for First Quarter 2025 on April 24, 2025

Dow Jones
·
13 Mar

Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
12 Mar

2seventy Bio Shares Soar Premarket on Deal to be Acquired by Bristol Myers

Dow Jones
·
11 Mar

2seventy Bio to be acquired by Bristol Myers for $5.00 per share in cash

TIPRANKS
·
11 Mar

2seventy Bio to be Acquired by Bristol Myers Squibb

MT Newswires Live
·
11 Mar

2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb

Business Wire
·
11 Mar

Myers Industries’ Earnings Call: Mixed Sentiment and Strategic Moves

TIPRANKS
·
11 Mar

Bristol Myers Stock Gains 9.2% in a Month: Should You Buy Now or Wait?

Zacks
·
11 Mar

EC Approves Bristol Myers' Opdivo Plus Yervoy for First-Line HCC

Zacks
·
10 Mar

Bristol Myers announces data from Phase 3 POETYK PsA-2

TIPRANKS
·
10 Mar

Dividend Investors: Don't Be Too Quick To Buy Myers Industries, Inc. (NYSE:MYE) For Its Upcoming Dividend

Simply Wall St.
·
09 Mar

Bristol Myers Squibb Presents Late-Breaking Data from Phase 3 POETYK PsA-2 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared with Placebo in Adults with Psoriatic Arthritis

Business Wire
·
08 Mar

Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
08 Mar

Why Myers Industries, Inc. (MYE) Soared on Thursday

Insider Monkey
·
08 Mar